Surgical robotics remains a hot area in medtech — even as it faces headwinds from the COVID-19 pandemic. Intuitive Surgical (NSDQ:ISRG) pioneered robotic surgery through the early 2000s and remains the dominant player, but major companies including Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) have big plans to enter the space and compete. Meanwhile, Stryker (NYSE:SYK) has built a […]
DTW Podcast: 3 lessons learned from Leslie Trigg, CEO of Outset Medical
Outset Medical (NSDQ:OM) CEO Leslie Trigg took the helm at the dialysis start-up in 2013, moving from an executive-in-residence post at private equity firm Warburg Pincus. Before that she held senior positions at Lutonix, AccessClosure and FoxHollow, helping to position those companies to be acquired by CR Bard, Cardinal Health, and ev3/Covidien, respectively. This week, […]
Former Corindus CEO Toland joins medtech investment firm
BioStar Capital announced today that former Corindus Vascular Robotics CEO Mark Toland has joined the firm as a partner and EIR. As a partner and entrepreneur in residence (EIR), Toland is slated to help in the discovery, development and nurturing of new startups with high-growth potential. He will also have the flexibility to function in […]
Report: Mayo Clinic to try Corindus telestenting
Mayo Clinic researchers this spring plan to try out Corindus’ telestenting technology — which Mayo officials think could improve care in the rural hospitals in their network, according to a report in the Star Tribune of Minneapolis. Corindus told MassDevice‘s sister site Medical Design & Outsourcing in 2018 that the company had a partnership with […]
Siemens Healthineers closes $1B Corindus Vascular Robotics buy
Siemens Healthineers said it today completed its $1.1 billion buyout of Corindus Vascular Robotics and its robot-assisted device for coronary and peripheral vascular procedures. Last week Corindus shareholders approved the merger, in which the German firm put up $4.28 per common share and $85.60 per Series A convertible preferred share. Today Siemens Healthineers said former […]
Corindus Vascular Robotics shareholders OK $1B Siemens Healthineers takeover
Corindus Vascular Robotics (NYSE:CVRS) said today that its stockholders approved the adoption of a $1.1 billion merger with with Siemens (NYSE:SI). Waltham, Mass.-based Corindus said the transaction is slated to close Oct. 29, after which Corindus will be delisted from the New York Stock Exchange, according to a news release. Corindus stockholders are set to receive $4.28 per […]
Corindus looks to forestall investor suits ahead of $1B Siemens buyout
Corindus Vascular Robotics (NYSE:CVRS) moved to forestall a group of lawsuits brought over its pending $1.1 billion merger with Siemens Healthineers (NYSE:SI). Corindus announced August 9 that it was set to be acquired by Siemens in an all-cash deal for $4.28 per CVRS share. The announcement prompted six lawsuits alleging that Corindus provided incomplete and misleading financial projections […]
First remote robotic PCI surgeries performed in India
A cardiologist in India has performed the first remote robot-assisted percutaneous coronary intervention procedures (R-PCIs), according to a new study published this week. The cardiologist used Corindus Vascular Robotics‘ CorPathGRX system and performed the five successful procedures from 20 miles away, according to an article on the study published in The Lancet’s EClinicalMedicine. The primary […]
FTC clears $1.1B Corindus buyout by Siemens Healthineers
Corindus Vascular Robotics (NYSE:CVRS) said today that the U.S. Federal Trade Commission granted early termination of the waiting period on its $1.1 billion acquisition by Siemens Healthineers (NYSE:SI). The all-cash deal for Waltham, Mass.-based Corindus, which is developing a robot-assisted device for vascular procedures, calls for the German conglomerate’s healthcare arm to pony up $4.28 per share. […]
Siemens to acquire Corindus in $1.1B deal
Corindus Vascular Robotics (NYSE:CVRS) reported its second-quarter financials today, revealing that it inked a deal to be acquired by Siemens Healthineers (NYSE:SI) in an all-cash deal valued at roughly $1.1 billion. Siemens Medical Solution, a subsidiary of Siemens Healthineers, is slated to acquire all issued and outstanding common stock in Corindus for $4.28 apiece in cash. The […]
EuroPCR 2019: Elixir Medical touts DynamX
Elixir Medical touted clinical and imaging results from a study of its DynamX drug-eluting stent, which is designed to restore normal pulsatility and adaptive remodeling in blood vessels after treating a coronary lesion. DynamX, introduced in 2017 at the annual Transcatheter Cardiovascular Therapeutics meeting, is a cobalt-chromium stent with a biodegradable polymer coating that releases novolimus. […]
- 1
- 2
- 3
- …
- 7
- Next Page »
